ing. D.F. Samplonius

E-mail:
d.f.samplonius umcg.nl

Research

Publications
  1. Bispecific Antibody Approach for Improved Melanoma-Selective PD-L1 Immune Checkpoint Blockade

    Koopmans, I., Hendriks, M. A. J. M., van Ginkel, R. J., Samplonius, D. F., Bremer, E. & Helfrich, W., Nov-2019, In : Journal of Investigative Dermatology. 139, 11, p. 2343-+ 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  2. Quantitative proteomics analysis identifies MUC1 as an effect sensor of EGFR inhibition

    de Boer, H. R., Pool, M., Joosten, E., Everts, M., Samplonius, D. F., Helfrich, W., Groen, H. J. M., van Cooten, S., Fusetti, F., Fehrmann, R. S. N., de Vries, E. G. E. & van Vugt, M. A. T. M., 28-Feb-2019, In : ONCOGENE. 38, 9, p. 1477-1488 12 p.

    Research output: Contribution to journalArticleAcademicpeer-review

  3. A novel bispecific antibody for EGFR-directed blockade of the PD-1/PD-L1 immune checkpoint

    Koopmans, I., Hendriks, D., Samplonius, D. F., van Ginkel, R. J., Heskamp, S., Wierstra, P. J., Bremer, E. & Helfrich, W., 2018, In : OncoImmunology. 7, 8, 11 p., 1466016.

    Research output: Contribution to journalArticleAcademicpeer-review

View all (29) »

View graph of relations

ID: 214592